Evidence map›Paper›PMID 41500613›Full record

ArticleBMJ open ophthalmology2026

Tumour control, eye retention and visual acuity after radiotherapy for choroidal melanoma.

Patrick Murtagh, Matthew M O'Riordan, Valerie O'Neill, Moya Cunningham, Fiona D'Arcy, Antonio Eleuteri, Alison Greene, Caroline Baily, Susan Kennedy, Rumana Hussain and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Patrick MurtaghRoyal Victoria Eye and Ear Hospital, Dublin, Ireland murtagp@tcd.ie.ORCID http://orcid.org/0000-0002-1892-459X
Matthew M O'RiordanRoyal Victoria Eye and Ear Hospital, Dublin, Ireland.ORCID http://orcid.org/0000-0002-1268-7423
Valerie O'NeillRoyal Victoria Eye and Ear Hospital, Dublin, Ireland.
Moya CunninghamDepartment of Radiation Oncology, St. Luke's Hospital, Dublin, Ireland.
Fiona D'ArcyRoyal Victoria Eye and Ear Hospital, Dublin, Ireland.
Antonio EleuteriLiverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK.
Alison GreeneRoyal Victoria Eye and Ear Hospital, Dublin, Ireland.
Caroline BailyRoyal Victoria Eye and Ear Hospital, Dublin, Ireland.
Susan KennedyRoyal Victoria Eye and Ear Hospital, Dublin, Ireland.
Rumana HussainLiverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK.
Heinrich HeimannLiverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, UK.
Noel HorganRoyal Victoria Eye and Ear Hospital, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveRadiotherapy modalities such as iodine-125 (I METHODS AND ANALYSIS: A review was conducted of all cases of choroidal melanoma treated with Ru

resultsA total of 310 eyes from 310 patients were included, comprising 175 patients (56.5%) treated with Ru

conclusionsEach radiotherapy modality demonstrated high rates of local tumour control and globe retention. The predictive nomogram may serve as a practical tool to support individualised visual prognostication and patient counselling in the management of choroidal melanoma.

Indexed as

BrachytherapyChoroid NeoplasmsIodine RadioisotopesMelanomaProton TherapyRuthenium RadioisotopesVisual AcuityAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesIodine-125Iodine RadioisotopesRuthenium-106Ruthenium RadioisotopesChoroidNeoplasia

Identifiers

PMID41500613
PMCPMC12778298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.